Canine Atopic Dermatitis: Welfare and Long-Term Management

Atopic dermatitis is the most common chronic skin disease in dogs, causing intense pruritus and secondary infections that severely impair quality of life, requiring long-term multimodal management.

Key Facts

Canine atopic dermatitis affects approximately 10-15% of the dog population
West Highland White Terriers, Golden Retrievers, Labrador Retrievers, and Bulldogs are commonly affected
Signs include facial rubbing, foot licking, axillary and groin irritation, and recurrent ear and skin infections
IgE-mediated hypersensitivity to environmental allergens including dust mites, pollens, and moulds is the primary mechanism
Novel targeted treatments including oclacitinib, lokivetmab, and dupilumab have transformed management options

Welfare Considerations

Atopic dermatitis causes chronic and often severe pruritus that compels affected dogs to scratch, lick, and bite at their skin day and night, disrupting sleep and normal behaviour. Secondary bacterial and yeast infections amplify discomfort, creating a cycle of inflammation and infection. The chronic nature of the condition means dogs may live with significant skin discomfort for years. Novel treatments targeting specific inflammatory pathways have dramatically improved welfare outcomes for many dogs, providing better and faster itch control than traditional approaches. Early diagnosis and specialist referral improves long-term welfare outcomes.

What You Can Do

Seek veterinary assessment for any dog with recurrent itching or skin infections that persist beyond 4-6 weeks
Ask for referral to a veterinary dermatologist if initial treatments do not provide adequate itch control
Discuss all available treatment options including novel targeted therapies with your veterinary team
Implement environmental allergen reduction measures as part of a comprehensive management plan